Comera Life Sciences Holdings, Inc.·4

Sep 12, 5:25 PM ET

Campbell Michael Gerard 4

4 · Comera Life Sciences Holdings, Inc. · Filed Sep 12, 2022

Insider Transaction Report

Form 4
Period: 2022-09-08
Campbell Michael Gerard
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-09-08$2.07/sh+25,000$51,75025,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.985 to $2.13, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES